FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2584962914> ?p ?o ?g. }

• W2584962914 endingPage "272" @default.
• W2584962914 startingPage "272" @default.
• W2584962914 abstract "272 Background: Over 17,000 patients are diagnosed with muscle-invasive bladder cancer (MIBC) in the United States each year. Despite its lethal potential, emerging data has suggested that many patients do not receive aggressive therapy consistent with established practice standards. Using data from American College of Surgeons Commission on Cancer accredited facilities, we seek to characterize treatment patterns for patients with MIBC according to demographic, clinical, pathologic and facility variables. Methods: 28,691 adult patients diagnosed with MIBC (stages II-IV), excluding those with T4b tumors or distant metastases between 2004 and 2008 were selected for analyses from the National Cancer Database. Treatments included radical or partial cystectomy +/− chemotherapy (CT), chemoradiotherapy (CRT), radiotherapy (RT) or CT alone and surveillance. Aggressive therapy (AT) was defined as any open surgery or RT with a total dose ≥50 Gy. Determinants of AT were assessed by multivariate generalized estimating equations accounting for facility clustering. Results: 52.5% of patients received AT (45% were treated surgically while 7.5% received CRT or RT), 11.7% received palliative CT or RT, and 25.9% received surveillance only. Receipt of AT decreased significantly with advancing age (OR 0.29 for age >80 vs. 18-59, p<.001). AT was also received less frequently by minorities (OR 0.72 for blacks p<.001), the uninsured (OR 0.72, p<.001), Medicaid-insured patients (OR 0.81, p=.006) and by those patients treated at low-volume centers (OR 0.63 vs. high-volume, p<.001). Receipt of AT increased with more advanced stage (OR 2.33 for stage III vs. stage II, p<.001) and in patients with non-urothelial histology (OR 1.32 and 1.50 for squamous and adenocarcinoma histology respectively, p<.001). Hydronephrosis was associated with decreased use of AT (OR 0.70, p<.001). Conclusions: Aggressive therapies for MIBC are received less frequently by the elderly and those with historically poorer socioeconomic status. These data indicate a significant unmet clinical need for physician education regarding appropriate selection of patients for cystectomy and RT-based bladder sparing therapy." @default.
• W2584962914 created "2017-02-10" @default.
• W2584962914 creator A5012866369 @default.
• W2584962914 creator A5019802090 @default.
• W2584962914 creator A5048513152 @default.
• W2584962914 creator A5062118116 @default.
• W2584962914 creator A5079764292 @default.
• W2584962914 creator A5085626001 @default.
• W2584962914 date "2012-02-10" @default.
• W2584962914 modified "2023-09-25" @default.
• W2584962914 title "Receipt of aggressive therapies for muscle-invasive bladder cancer: Results from the National Cancer Data Base." @default.
• W2584962914 doi "https://doi.org/10.1200/jco.2012.30.5_suppl.272" @default.
• W2584962914 hasPublicationYear "2012" @default.
• W2584962914 type Work @default.
• W2584962914 sameAs 2584962914 @default.
• W2584962914 citedByCount "1" @default.
• W2584962914 countsByYear W25849629142016 @default.
• W2584962914 crossrefType "journal-article" @default.
• W2584962914 hasAuthorship W2584962914A5012866369 @default.
• W2584962914 hasAuthorship W2584962914A5019802090 @default.
• W2584962914 hasAuthorship W2584962914A5048513152 @default.
• W2584962914 hasAuthorship W2584962914A5062118116 @default.
• W2584962914 hasAuthorship W2584962914A5079764292 @default.
• W2584962914 hasAuthorship W2584962914A5085626001 @default.
• W2584962914 hasConcept C121608353 @default.
• W2584962914 hasConcept C126322002 @default.
• W2584962914 hasConcept C143998085 @default.
• W2584962914 hasConcept C160735492 @default.
• W2584962914 hasConcept C162324750 @default.
• W2584962914 hasConcept C2775910329 @default.
• W2584962914 hasConcept C2776534028 @default.
• W2584962914 hasConcept C2778424827 @default.
• W2584962914 hasConcept C2780352672 @default.
• W2584962914 hasConcept C50522688 @default.
• W2584962914 hasConcept C509974204 @default.
• W2584962914 hasConcept C71924100 @default.
• W2584962914 hasConceptScore W2584962914C121608353 @default.
• W2584962914 hasConceptScore W2584962914C126322002 @default.
• W2584962914 hasConceptScore W2584962914C143998085 @default.
• W2584962914 hasConceptScore W2584962914C160735492 @default.
• W2584962914 hasConceptScore W2584962914C162324750 @default.
• W2584962914 hasConceptScore W2584962914C2775910329 @default.
• W2584962914 hasConceptScore W2584962914C2776534028 @default.
• W2584962914 hasConceptScore W2584962914C2778424827 @default.
• W2584962914 hasConceptScore W2584962914C2780352672 @default.
• W2584962914 hasConceptScore W2584962914C50522688 @default.
• W2584962914 hasConceptScore W2584962914C509974204 @default.
• W2584962914 hasConceptScore W2584962914C71924100 @default.
• W2584962914 hasIssue "5_suppl" @default.
• W2584962914 hasLocation W25849629141 @default.
• W2584962914 hasOpenAccess W2584962914 @default.
• W2584962914 hasPrimaryLocation W25849629141 @default.
• W2584962914 hasRelatedWork W1973041883 @default.
• W2584962914 hasRelatedWork W1987212190 @default.
• W2584962914 hasRelatedWork W2038776230 @default.
• W2584962914 hasRelatedWork W2079205857 @default.
• W2584962914 hasRelatedWork W2120921122 @default.
• W2584962914 hasRelatedWork W2164361265 @default.
• W2584962914 hasRelatedWork W2331564269 @default.
• W2584962914 hasRelatedWork W2528981680 @default.
• W2584962914 hasRelatedWork W2728560941 @default.
• W2584962914 hasRelatedWork W3136529388 @default.
• W2584962914 hasVolume "30" @default.
• W2584962914 isParatext "false" @default.
• W2584962914 isRetracted "false" @default.
• W2584962914 magId "2584962914" @default.
• W2584962914 workType "article" @default.